Consumer staples occupy a unique niche in ETF investing: they target everyday essentials — food, beverages, household goods, and tobacco — whose demand tends to hold up through economic slowdowns. Comparing FSTA and KXI is timely because both claim the same defensive sector yet deliver it through very different structural lenses. FSTA is a pure-play bet on U.S. staples giants, while KXI extends the same theme across developed and select emerging markets. They do not compete as identical products; rather, they represent a classic trade-off between domestic concentration and cost efficiency versus global diversification. For investors evaluating sector exposure, fund performance, and relative positioning in an uncertain macro cycle, understanding these structural differences is essential. I also checked this using Tickeron’s AI Screener to see how the two approaches line up on recent trends.
FSTA is a passively managed index fund that seeks to replicate the MSCI USA IMI Consumer Staples 25/50 Index, which captures the U.S. consumer staples equity market. The fund typically holds roughly 100 stocks, spanning large-, mid-, and small-cap names, though it is heavily tilted toward sector leaders. Its top holdings include WMT (Walmart), COST (Costco Wholesale), PG (Procter & Gamble), KO (Coca-Cola), and PEP (PepsiCo), with further meaningful positions in PM (Philip Morris International), MO (Altria Group), MDLZ (Mondelez International), CL (Colgate-Palmolive), and MNST (Monster Beverage). Its expense ratio of 0.08% makes it among the cheapest ways to own the sector. The fund is non-diversified by regulatory classification and carries a defensive profile, with a five-year beta well below 1.0. From what I see, the concentration in a handful of U.S. leaders gives it a clear edge in recent cycles.
KXI is a passively managed fund that tracks the S&P Global 1200 Consumer Staples Sector Capped Index, drawing from roughly 1,200 global large-cap equities to build a basket of about 95 to 100 consumer staples names. Its top holdings overlap with FSTA — WMT, COST, PG, KO, and PM — but at materially lower weights, because the index adds global giants such as Nestlé, Unilever, and British American Tobacco. Geographically, roughly 57% of assets are U.S. equities, with the remainder spread across the United Kingdom, Switzerland, Japan, France, and other markets. The fund carries an expense ratio of about 0.39% and a heavier tobacco weighting than FSTA. Like FSTA, KXI is a low-beta, defensive vehicle, but its non-U.S. sleeve introduces currency risk and a different earnings and valuation mix.
The consumer staples sector is being shaped by several durable forces. Persistent inflation and elevated borrowing costs have pressured household budgets, yet staples demand has remained comparatively resilient, favoring scale leaders with pricing power. Mega-cap retailers such as Walmart and Costco continue to gain share through membership, e-commerce, and value positioning, while branded packaged-goods companies navigate volume-versus-price trade-offs. Geographically, a stronger U.S. dollar has historically weighed on non-U.S. earnings translated back into dollars — a headwind more relevant to KXI than FSTA. Regulatory scrutiny around tobacco and packaged foods, shifting consumer health preferences, and GLP-1 weight-loss drug adoption are additional structural risks. Meanwhile, staples have served as a defensive anchor as investors rotate capital toward quality and cash-generative names amid macro uncertainty.
In recent weeks and months, both funds have delivered the defensive stability investors expect, but their relative positioning has diverged. FSTA has benefited from its concentrated exposure to U.S. leadership names — Walmart, Costco, and Coca-Cola — whose earnings momentum and domestic demand have supported outperformance across recent market cycles. KXI's broader basket, including European and Japanese staples, has been tempered by slower international growth, currency translation effects, and a larger tobacco allocation. FSTA's lower expense ratio compounds this advantage over time, and its tighter concentration amplifies the impact of its strongest holdings. KXI, by contrast, offers smoother diversification and reduced single-country risk. On a volatility basis, both funds register beta below the broader market, but KXI's currency exposure can introduce additional day-to-day fluctuation that a pure U.S. fund avoids. Overall, recent relative performance has favored the cost-efficient, U.S.-centric structure of FSTA. I’m watching this closely as the cost gap continues to widen the performance differential.
Based on observable structural factors, Tickeron's AI would currently lean toward FSTA. The reasoning is probabilistic rather than prescriptive: FSTA offers a materially lower expense ratio (0.08% versus roughly 0.39%), concentrated exposure to the strongest U.S. staples franchises that have sustained earnings and trend consistency across recent cycles, and a cleaner single-currency profile. While KXI provides valuable geographic diversification and reduced single-market concentration, its higher cost, currency drag, and heavier tobacco weighting have tempered its relative momentum. On a balance of cost efficiency, trend consistency, and sector-momentum alignment, FSTA presents the more favorable risk-adjusted structure at present. This is an analytical assessment, not personalized investment advice.
I often turn to Tickeron’s AI Screener when comparing sector ETFs like these. It lets me quickly filter holdings, trends, and relative strength across thousands of names using technical patterns and fundamentals. In this case, it helped confirm how FSTA’s U.S. concentration stacks up against KXI’s broader global mix. The tool keeps the process efficient without replacing my own judgment on costs and risk factors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for KXI turned positive on October 08, 2026. Looking at past instances where KXI's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on KXI as a result. In 68 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
KXI moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KXI crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where KXI advanced for three days, in 243 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 208 of 278 cases where KXI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The 10-day RSI Indicator for KXI moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 24 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 65 cases where KXI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
KXI broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples